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ABSTRACT  
Recent work exploring protein sequence 
space has revealed a new glycoside hydrolase 
(GH) family (GH164) of putative mannosidases. 
GH164 genes are present in several commensal 
bacteria, implicating these genes in the 
degradation of dietary glycans. However, little is 
known about the structure, mechanism of action 
and substrate specificity of these enzymes. Herein 
we report the biochemical characterization and 
crystal structures of the founding member of this 
family (Bs164) from the human gut symbiont 
Bacteroides salyersiae. Previous reports of this 
enzyme indicated that it has α-mannosidase 
activity, however we conclusively show that it 
cleaves only β-mannose linkages. Using NMR 
spectroscopy, detailed enzyme kinetics of wild-
type and mutant Bs164, and multi-angle light 
scattering we found that it is a trimeric retaining 
β-mannosidase, that is susceptible to several 
known mannosidase inhibitors. X-ray 
crystallography revealed the structure of Bs164 – 
the first known structure of a GH164 – at 1.91 Å  
resolution. Bs164 is composed of three domains: 
a (β/α)8 barrel, a trimerization domain and a β-
sandwich domain, representing a previously 
unobserved structural fold for β-mannosidases. 
Structures of Bs164 at 1.80-2.55 Å resolution in 
complex with the inhibitors noeuromycin, 
mannoimidazole or DNP 2-deoxy-2-fluoro-
mannose reveal the residues essential for 
specificity and catalysis including the catalytic 
nucleophile (Glu297) and acid/base residue 
(Glu160). These findings further our knowledge 
of the mechanisms commensal microbes use for 
nutrient acquisition. 
 
Introduction 
Mannose is an essential component of 
protein human N-glycans (1), storage polymers – 
mannan and glucomannan in plants (2) and 
mannogen in Leishmania (3) –  and has even been 
observed to play a role in enzyme substrate 
recognition (4). Considering the roles of mannose 
containing polymers, it is no surprise that nature 
has developed a variety of enzymes to either 
modify the properties of these polymers or release 
their stored energy. The majority of enzymes that 
degrade mannose polymers are classified as 
glycoside hydrolases (GHs). The Carbohydrate 
Active Enzymes (CAZy) database (5) 
(http://www.cazy.org) categorizes all known GHs 
into > 160 families, including several with known 
mannosidase activity. A major focus of recent 
study has centred on how the enteric bacteria 
employ GHs to degrade variety of 
polysaccharides including the mannose polymers 
present in the human gut (6-10), resulting in a 
better understanding of degradation mechanisms 
that underpin the nutrient acquisition by 
commensal bacteria. 
Recent work by Helbert and co-workers 
(11) identified a new family of mannosidases: 
family GH164. This was accomplished through 
the combination of sequence space exploration, 
gene synthesis and high-throughput activity 
assays. The founding member of GH164 – which 
we shall herein refer to as Bs164 – originates from 
the enteric bacterium Bacteroides salyersiae 
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CL02T12C01 and was initially reported by the 
authors to have α-mannosidase activity. This 
family at present contains seventeen genes, the 
majority of which belong to host associated 
strains. However, due to the preliminary nature of 
this discovery very little is known about the 
structure, action mechanism or substrate 
specificity of GH164 enzymes.  
Here we present the detailed biochemical 
and structural analysis of Bs164. In contrast to 
initial reports, this enzyme has no α-mannosidase 
activity; instead, Bs164 cleaves β-mannosidic 
linkages in aryl b-mannosidase and 
mannooligosaccharides. X-ray crystal structures 
of Bs164 reveal a homo-trimeric quaternary 
structure with each individual chain containing 
three domains. The catalytic domain of Bs164 
consists of a (β/α)8 barrel with catalytic residues 
on β-strands 4 and 7 placing this family in clan 
GH-A. NMR analysis revealed a retaining 
mechanism and site directed mutagenesis 
confirmed the assignment of the nucleophile and 
acid/base catalytic residues. Structures of 
inhibitor complexes show the conserved catalytic 
machinery involved in substrate recognition and 
catalysis and provide insight into the likely 
conformational itinerary for mannoside 
hydrolysis. Taken together, this work provides a 
thorough biochemical basis for the β-mannoside 
hydrolysis catalyzed by GH164 enzymes. 
 
Results and Discussion 
Operonic context of GH164s 
  The GH164 genes present in the CAZy 
database are confined to the Bacteroidetes (5), a 
phylum that is well known for carbohydrate 
utilization operons (12). In addition to the GH164 
from B. saylersiae four genes originate from the 
Alistipes genus, commonly found in the human 
gut (13) , ten from the Capnocytophaga, typically 
found in the oralpharengyl tract (14), and one 
each belonging to the marine bacterium 
Flammeovirga and the lichen associated 
Mucilaginibacter. Examination of the operonic 
context of the GH164 gives some clue to the 
polysaccharides which they target (Figure 1). The 
locus surrounding Bs164 is limited to two other 
genes, a hybrid two component sensor (HTCS) 
and an arylsulfatase like protein, however the 
GH164 containing operons from Alistipes sp. 
5NYCFAH2 and Capnocytophaga sputigena 
NCTC11097, see figure 1A, are much more 
elaborate. Both of these operons contain a SusC 
and SusD-like protein – the hallmark of 
polysaccharide utilization loci (12) – as well as 
both endo and exo-acting GH families. The 
presence of GH5, a family that contains endo-β-
mannanases, and GH2, a family containing both 
β-galactosidases and β-mannosidases, and the 
absence of α-mannose targeting families suggests 
that these operons function to degrade dietary β-
mannan, glucomannan or galactomannan rather 
than N-glycans. The B. salyersiae genome also 
contains both GH5 and GH2 encoding genes 
suggesting that it may also target mannans, 
though with enzymes from separate loci.  
 
Bs164 is a retaining β-mannosidase 
The Bs164 protein containing an N-
terminal hexahistidine tag was purified using 
immobilized metal affinity chromatography 
followed by size exclusion chromatography. The 
hexahistidine tag was then removed using 3C 
protease, and the untagged protein was further 
purified using an additional size exclusion 
chromatography step. Bs164 eluted from the size 
exclusion earlier than would be expected for a 
74.4 kDa protein. To determine whether Bs164 
exists as a multimer in solution we subjected 
purified Bs164 to SEC-MALS (size exclusion 
chromatography with multi-angle light 
scattering). A single peak was observed with a 
calculated molecular mass of 227 kDa, signifying 
that Bs164 forms trimers in solution.  
To assess the substrate tolerance of Bs164 
we assayed the purified enzyme with a variety of 
synthetic aryl glycosides and 
mannooligosaccharides (see methods for 
complete list). Bs164 shows no activity towards 
D-xylose, D- or L-arabinose, D-galactose, D-
glucose, or L-fucose containing substrates. 
Furthermore no activity was observed towards α-
D-linked mannosides, contradicting the initial 
report of enzyme activity by Helbert et al (11). 
Bs164 did, however, have significant activity 
against β-linked aryl mannosides with a pH 
optimum 5.5 (Figure 2). This pH was used in 
assays to characterize the specificity if this 
enzyme towards β-mannoside hydrolysis (Table 
1). The specificity constant for pNP β-man 
hydrolysis was approximately 6 times that seen 
for MU β-man which we attribute to pNP being a 
slightly better leaving group.  This enzyme is also 
able to hydrolyse β-linked 
mannooligosaccharides and shows comparable 
specificity constants for the hydrolysis of 
mannobiose, mannotriose and mannotetraose 
(Table 1) indicating that it contains a +1 subsite, 
but that binding in the +2 position does not greatly 
increase hydrolysis rates.  The specificity 
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constants for mannooligosaccharide hydrolysis 
were also 2-5 times lower than those seen for pNP 
β-man, which we again attribute to the better 
leaving group ability of pNP.  
We next sought to determine whether 
Bs164 employs a mechanism that results in either 
inversion or retention of the stereochemistry at 
the anomeric center. We used 1H NMR 
spectroscopy to monitor the enzyme-catalyzed 
hydrolysis of paranitrophenyl β-D-
mannopyranoside (pNP β-man) over the course of 
time (Figure 3). This revealed that the β-anomer 
of mannose is produced immediately after the 
enzyme is added. The free mannose then 
undergoes mutorotation and the ratio between α- 
and β-anomers approaches equilibrium over time. 
This confirms that Bs164 is a retaining 
mechanism β-mannosidase and supports a 
mechanism that employs a nucleophile and an 
acid/base residue and transits through a glycosyl-
enzyme intermediate.  
 
Crystal structure of Bs164 reveals a trimeric 
quaternary structure  
 We solved the structure of Bs164 using 
seleno-methionine multi-wavelength anomalous 
dispersion data to 2.3 Å and native protein data to 
1.9 Å, see Table 2 for refinement statistics. The 
asymmetric unit of the P1 crystal form contains 
six Bs164 protomers arranged into two donut 
shaped trimers, consistent with the trimeric form 
seen in solution (Figure 4A). Each trimer-donut 
has an outer diameter of approximately 100 Å and 
an internal diameter of between 30 and 35 Å. The 
individual Bs164 chains contain three clearly 
defined domains: a modified (β/α)8 barrel 
(residues 22 - 389), a domain containing a seven 
membered mixed β-sheet sandwiched between α-
helices (390-609), and a β-sheet domain (610-
681) (Figure 4B). This domain architecture is 
quite similar to that seen for family GH42 
enzymes (15), but is previously unseen for β-
mannosidases. Furthermore, analysis using the 
DALI server (16) indicates that the structure with 
highest similarity to Bs164 (RMSD = 2.4 Å, Z-
score = 22.8, 100 % coverage) is indeed a GH42 
β-galactosidase from Bacillus circulans sp. 
alkalophilus (PDB ID: 3TTY) also with trimeric 
quaternary structure (17).  
 The (β/α)8 fold of domain A is found in 
the catalytic domain of many glycoside 
hydrolases and is a distinctive feature of clans 
GH-A, D, K and R. Domain A also contains a 
helix containing subdomain – atypical of (β/α)8 
folds but also observed in the GH42 family (15) – 
that is present between the 4th β-strand and the 
next α-helix. This domain projects along the side 
of the domain B and interacts with domain A of a 
neighbouring chain (Figure 4B). We speculate 
that the presence of this domain helps, in part, to 
stabilize the trimeric structure. Domain A shows 
highest similarity – by means of a Dali search (16) 
– to the catalytic domain from the GH42 β-
galactosidase from Rahnella sp. (PDB: ID code 
5E9A) with RMSD of 3.2 Å and complete query 
coverage (18). Overlay of these two structures 
revealed that the nucleophile (Glu314 in 5E9A) 
and acid/base residue (Glu157 in 5E9A) are 
conserved in Bs164 and the putative catalytic 
nucleophile and acid/base are Glu297 and Glu160 
respectively. Comparison of amino acid 
conservation within the GH164 family also shows 
that this active site is completely conserved across 
the family (Figure 5). The positioning of the 
catalytic residues on strands 4 (acid/base) and 7 
(nucleophile) indicate that the GH164 belongs to 
clan GH-A glycoside hydrolases, which contains 
in addition to GH42, several other families whose 
members are active on β-mannose linkages, 
namely: GH2, GH5, GH26 and GH113. 
The active site of Bs164 is a shallow pocket 
that has a much more open + binding subsites than 
is seen in the exo-mannosidases BtMan2A (9) and 
CmMan5A (19). Both BtMan2A and CmMan5A, 
contain tryptophan residues – Trp470, for 
BtMan2A and Trp135 for CmMan5A – in the 
positive subsites, constraining the active site, and 
creating a more tunnel like environment, whereas 
Bs164 lacks an aromatic residue in a similar 
position.  Although the positive subsites of Bs164 
are more open, there are some interactions which 
are consistent with other mannosidases. The 
residue His264 in particular most resembles a 
positive subsite interaction residue seen in other 
mannosidases. His264 residue is in the same 
position as both Trp289 in CmMan5A and Trp519 
in BtMan2A, which are thought to form a part of 
the +2 subsite in these proteins. The complete 
conservation of His264 across the GH164 family, 
and its positioning suggests that this residue 
forms part of the +2 subsite in Bs164.  
In addition to the active site, domain A also 
contains a chloride-binding site. The chloride ion 
coordinates Gln45, Thr110, and two arginine 
residues (Arg73 and Arg75) in a penta-
coordinate, distorted square pyramidal geometry, 
(see Figure 4D). The chloride is present is 
observed in all 6 chains in the crystal structure 
and is observed in all of the inhibitor complexes 
described below. This chloride is present at a site 
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adjacent to the active site and one of the 
coordinating arginines – Arg73 – and forms a 
direct interaction with the catalytic nucleophile. 
Additionally, Arg75 projects into the active site 
and the two η-nitrogens form hydrogen-bonds 
with the 2- and 3-hydroxyls of the sugar residue 
bound at the –1 subsite, as will be described 
below.  
Domain B bears a striking resemblance to 
the trimerization domain of GH42 enzymes. In 
GH42 structures (15,18,20) there are a number of 
interactions between the trimerization domain 
and the catalytic domain which support trimeric 
quaternary structure. Likewise, domain B of 
Bs164 interacts over a surface area of 1380 Å2 per 
protomer that includes seven residues involved in 
direct hydrogen bonds and two salt bridges 
between chains. The corresponding interface in 
domain A consists of the loops connecting the last 
two pairs of β-sheets and α-helices. This 
trimerization also likely has a role in catalysis as 
the interaction of residues Ser342-Ala345 and 
Ala347 in domain A with the domain B of the 
neighbouring protomer appears to help position 
the active site residues Arg341 and Glu346 that 
interact directly with the substrate, as shown in 
the inhibitor bound structures which are described 
in the next section.  
Unlike the first two domains, the function 
of the C-terminal β-sandwich domain is much 
more difficult to infer from the structure. This 
domain is also present in GH42 enzymes 
(15,18,20) however, the role of this domain 
within GH42s is unknown.  
 
Active centre structure and catalysis  
To gain further insight into the mechanism 
and substrate recognition and confirm the 
assignment of the catalytic residues we produced 
structures of Bs164 in complex with 2,4-
dinitrophenyl 2-deoxy-2-fluoro-mannoside 
(DNP-2FM), noeuromycin and mannoimidazole 
through soaks of Bs164 crystals. Mannoimidazole 
and noeuromycin act as competitive inhibitors of 
Bs164 with inhibition constants (Ki) of 470 ± 60 
µM and 340 ± 40 nM respectively. The inhibiton 
constant for noeuromycin is well in line with 
previous reports of β-mannosidase inhibiton 
(21,22), however inhibition by mannoimidazole 
notably is much worse than is seen for other β-
mannosidases such as BtMan2A (Ki = 1.4 µM) 
(21). The fluorosugar DNP-2FM is a mechanism 
based inhibitor which forms a glycosyl-enzyme 
intermediate that is turned over at much slower 
rates than the natural sugar, thereby enabling the 
identification of the catalytic nucleophile (23). 
All three of these inhibitors are present in the 
Bs164 active site –1 subsite (Figure 6).  
The mannosidase inhibitors are recognized 
in the –1 subsite by eight polar amino acids, 
which are within hydrogen bonding distance to 
the substrate (Figure 6). All eight of these polar 
contacts are completely conserved across all 
GH164s currently within the CAZy database, and 
form similar interactions with each of the 
inhibitors. The O6 sits, pointing towards the β-
face between the carbonyl of Glu346 and the 
indole nitrogen of Trp263. Glu346 is also 
positioned to hydrogen bond O4 of the inhibitors, 
the Glu-O4-O6 motif is seen in a number of 
mannosidase structures including those for GH1 
(PDB ID: 4RE2) (24), GH2 (PDB ID: 2VMF) 
(21), and GH5 (PDB ID: 1UZ4) (22). The O4 of 
all inhibitors hydrogen bonds with Arg341, is part 
of a loop that interacts with the trimerization 
domain of the neighbouring protomer. Another 
arginine, Arg75 (which is bound to chlorine) 
hydrogen bonds to O3 of all inhibitors and the O2 
of mannoimidazole and noeuromycin. Arg75 lies 
below the sugar plane and likely provides impetus 
for the O2 axial to equatorial migration, the 
presence of an arginine bridging the O2 and O3 
hydroxyls is also seen in the GH113 β-mannanase 
AaManA (25). The O2 hydroxyl also hydrogen 
bonds to Asn159 in all three inhibitor structures 
and the nucleophile (Glu297) in mannoimidazole 
and noeuromycin structures. The hydrophobic 
element on the α-face of the sugar is provided by 
Trp336, well within range to form CH-π 
interactions – a motif which is often seen in 
protein-β-mannose interactions (26).  
The structure of bound 2FM clearly shows 
a covalent intermediate attached to Glu297, this 
observation along with kinetic analysis of an 
E297Q variant conclusively identifies Glu297 as 
the active site nucleophile. The acid/base residue, 
Glu160 is positioned to perform anti-protonation 
of the leaving group, typical of clan GH-A 
glycoside hydrolases (27). This residue forms 
hydrogen bonding interactions with both the 
endocyclic nitrogen in noeuromycin and 
imidazole nitrogen in mannoimidazole, an 
interaction which is also seen in GH26 and 
GH113 β-mannanases (25) and GH2 β-
mannosidases (21). Further evidence, in the form 
of near complete loss of activity by the E160Q 
variant (see Table 1) confirms the assignment of 
Glu160 as the acid/base residue.  
The inhibitor bound structures of Bs164 
also give insight into the conformational itinerary 
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of β-mannoside hydrolysis. Most β-mannosidases 
and β-mannanases, including families GH2, GH5, 
GH26, GH113 and GH130 have been observed to 
transit through a 1S5 à B2,5‡ à OS2 glycosylation 
itinerary (28), the outlier being the inverting 
enzyme GH134 which instead proceeds through 
1C4 à 3H4‡ à 3S1 (see reference (29)). The 
structure of the mannoimidazole – an inhibitor 
which faithfully reports on the transition state of 
mannosidases (21,25,28,30) – is clearly in a B2,5 
conformation within the Bs164 active site (figure 
6, B) indicating that the conformational itinerary 
is centred, as for most β-mannosidases, around a 
B2,5 transition state. The structure of the 
noeuromycin complex, in which a 1S5 
conformation is observed (figure 6A), lends 
further support to this itinerary. Observations 
from other β-mannosidases (28,31) suggest we 
should expect the glycosyl-enzyme intermediate 
to adopt a OS2 conformation, however, in the 
complex with 2FM the ring is in a 4C1/E5 
conformation (φ = 295°, θ =37°) with the 2F 
positioned axially, instead of equatorially as 
would be expected in a OS2 conformation. The 
comparatively low resolution of the 2FM 
structure (2.55 Å) makes it difficult to 
equivocally confirm the conformation of the 
glycosyl-enzyme intermediate that appears to 
refine as 4C1/E5. We endeavour to further explore 
the energetic consequences of this 4C1/E5 
conformation and whether this is the structure is 
representative of the true glycosyl-enzyme 
intermediate or an energetic relaxation of this 
intermediate to a position that is not along the 
conformational itinerary. 
 
Conclusions 
The capacity of commensal bacterial to 
digest dietary carbohydrates relies on a broad 
range of enzymes, tailored to their specific target. 
Examination of Bs164, the prototypical GH164, 
adds to our growing understanding of the 
mechanisms underpinning enteric carbohydrate 
degradation.  Our interrogation of this enzyme 
has shown that it exists as a donut shaped 
homotrimer – a new domain architecture and 
quaternary structure for β-mannosidases – and 
employs two conserved glutamic acid residues in 
a retaining mechanism. The structural analysis of 
Bs164 in the presence of inhibitors revealed a host 
of active site interactions and suggested a boat-
like transition state. Further investigation of how 
the genes co-localized within GH164 containing 
operons, promises to reveal how these loci 
function in concert to enable degradation of 
mannose containing polymers within the human 
microbiome.  
 
Experimental procedures 
Substrates and Inhibitors 
Paranitrophenyl β-D-mannopyranoside and 
methylumbelliferyl β-D-mannopyranoside were 
purchased from Sigma-Aldrich. Mannobiose, 
mannotriose and mannotetraose were purchased 
from Megazyme (Bray, Ireland). 
Mannoimidazole and noeuromycin were kind 
gifts from Professor Spencer Williams and 
Professor Robert V. Stick, respectively. 2,4-
dinitrophenyl 2-deoxy-2-fluoro-β-D-
mannopyranoside was a kind gift from Professor 
Stephen G Withers (University of British 
Columbia).  
 
Gene expression and protein purification 
The gene encoding Bs164 (GenBank 
accession EIY59668.1) was predicted to contain 
a signal peptide with a cleavage site between 
amino acids 21 and 22 by signalP 5.0 (32) . A 
codon optimized version of this gene with a hexa-
histidine tag in place of the signal peptide 
(MGSSHHHHHHSSGLEVLFQGPA) was 
synthesized by and cloned into a pET-28 vector 
by Genscript (Leiden, Netherlands). Plasmid was 
transformed into chemically competent BL21 
(DE3) gold cells (Agilent) and plated on LB agar 
containing 50 µg/mL kanamycin. A single colony 
was used to inoculate a 5 mL of LB media 
containing 50 µg/mL kanamycin. After overnight 
growth at 37 ºC with shaking at 180 rpm this 
starter culture was used to inoculate NZYTech 
auto-induction media (NZYTech) containing 50 
µg/mL kanamycin. Expression cultures were 
grown at 37 ºC with shaking at 250 rpm for 6 h, 
the temperature was then decreased to 20 ºC and 
cultures were incubated for an additional 22 h. 
Expression cultures were harvested by 
centrifugation (5,000 x g, 30 min, 4 ºC) and cell 
pellets were stored at -80 ºC until purification. 
To purify the protein cell pellets were 
resuspended in 120 mL of Buffer A (50 mM 
HEPES, 30 mM imidazole, 200 mM NaCl, pH 
7.4) with additional protease inhibitor (4-[2-
aminoethyl]benzenesulfonyl fluoride, 0.1 mM) 
lysozyme, and DNAse. Resuspended cells were 
then lysed by passage through a cell-disruptor 
homogenizer at 25 kpsi. Lysed cells were 
centrifuged (18,000 x g, 30 min, 4 ºC) and the 
supernatant was decanted from the cell debris. 
Clarified supernatant was loaded directly onto a 5 
mL Histag Excel column (GEHealthcare). Bound 
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protein was washed with 7.5 column volumes of 
buffer A then eluted with a linear gradient of 0- 
100 % buffer B (50 mM HEPES pH 7.4, 1 M 
imidazole, 200 mM NaCl) over 20 column 
volumes. Eluted protein was concentrated with a 
30 kDa cut-off Amicon centrifugal filter unit and 
further purified by gel filtration (HiLoad 16/600 
Superdex 200 pg; GE Healthcare) in buffer C (50 
mM HEPES, 200 mM NaCl, pH 7.4). The purity 
of eluted protein was analysed by SDS-PAGE and 
the peak fractions were pooled and concentrated 
with a 30 kDa cutoff Amicon centrifugal filter 
unit. Concentrated protein was washed with 
buffer D (20 mM HEPES, pH 7.4) then diluted to 
30 mg/mL with buffer D and flash frozen with 
liquid nitrogen until use. Protein concentrations 
were determined spectrophotometrically using a 
calculated A280 extinction coefficient of 128,480 
M-1cm-1. For biochemical studies, the N-terminal 
hexa-histidine tag was cleaved from Bs164 
through overnight incubation with a 1:100 ratio 
(by mass) of 3C-protease. Cleaved Bs164 was 
then purified by gel filtration and concentrated as 
detailed above. The average yield of purified 
protein was approximately 30 mg per litre of 
culture.  
Seleno-methionine labelled protein was 
expressed using the same bacterial strain as for 
the wild-type protein. This strain was used to 
inoculate 40 mL LB media containing 50 µg/mL 
kanamycin which was grown overnight at 37 ºC. 
This culture was then centrifuged (3,000 x g, 10 
min, 4 °C) and the cell pellet was resuspended in 
40 mL of M9 media containing 50 µg/mL 
kanamycin. The resuspended cells (1 mL) were 
then used to inoculate a 1 L culture of M9 media 
containing 50 µg/mL kanamycin. This culture 
was incubated at 37 ºC with shaking at 250 rpm 
until mid-log phase (OD600 = 0.5). At this point 
lysine (100 mg/L), phenylalanine (100 mg/L), 
threonine (100 mg/L), isoleucine (50 mg/L), 
leucine (50 mg/L), valine (50 mg/L) and seleno-
methionine (50 mg/L) were added to the culture, 
which was incubated for another 15 min at 37 °C. 
The incubation temperature was then lowered to 
20 °C and IPTG was added to a final 
concentration of 0.5 mM. After incubation for 18 
h the cultures were harvested as for the unlabelled 
protein. The seleno-methionine protein was 
purified as for the unlabelled protein except for 
the addition of 5 mM DTT to buffers A, B and C 
and the addition of 0.5 mM TCEP to buffer D.  
Mutagenesis was performed using a 
modified Quikchange™ (Agilent) protocol. For 
each mutant generated, PCR was first performed 
for 12 cycles with one of the sense or antisense 
primers (E288Q_F: GTG GCT GAT GAC CCA 
ACT GCA AGG TG, E288Q_R: CAC CTT GCA 
GTT GGG TCA TCA GCC AC, E151Q_F: GTG 
CTG ATT AAC CAG CCG GGT ACC C, 
E151Q_R: GGG TAC CCG GCT GGT TAA 
TCA GCA C); these two reactions were 
subsequently pooled, and an additional 18 cycles 
of PCR were performed. PCR products were 
digested with DpnI (NEB) and transformed into 
chemically competent BL21 (DE3) gold cells. 
Purified plasmids were sequenced to confirm the 
correct mutation prior to expression. Both the 
nucleophile and acid base variants were purified 
as for the wild-type protein.  
 
Activity assays  
All Bs164 activity assays, unless otherwise 
stated, were performed at 25 ºC in a buffer 
containing 80 mM MES pH 5.5 and 160 mM 
NaCl, and were initiated by the addition of the 
appropriate amount of enzyme. Purified Bs164 
was initially tested for activity on the following 
aryl glycosides: pNP α-L-arabinofuranoside, pNP 
α-L-arabinopyranoside, pNP α-L-fucopyranoside, 
pNP β-D-galactopyranoside, pNP α-D-
glucopyranoside, pNP β-D-glucopyranoside, pNP 
α-D-mannopyranoside, pNP β-D-
mannopyranoside, and pNP β-D-xylopyranoside. 
Purified enzyme was added (final concentration 
of 1 µM) to a solution of 1 mM substrate. These 
assays were incubated at 25 ºC and were stopped 
after 6 h with a 1:1 ratio of 1M Na2CO3 (pH 11.2) 
and absorbance at 400 nm was measured with a 
CLARIOstar Plus plate reader (BMG Labtech). 
The optimal pH for activity was 
determined with methylumbelliferyl β-D-
mannopyranoside (MU β-man) using substrate 
depletion kinetics. Purified enzyme was added to 
solutions containing 50 µM MU β-man, 160 mM 
NaCl and either MES (pH 5-6.5) or HEPES (pH 
6.5-8.5). Reactions were limited to this pH range 
as enzyme denaturation was observed above pH 
8.5 and below pH 5. Fluorescence was monitored 
continuously (λex = 365 nm, λem = 450 nm) and 
depletion curves were fit to the equation A = Af(1-
e-kt), where k = [E] ·kcat/KM , to give the specificity 
constant at each pH.  
Kinetic parameters were determined for 
pNP β-Man and MU β-Man using substrate 
concentrations covering the range of 1/5 to 5 
times the eventual KM determined. Assays were 
performed in 96 well plates and each plate 
included either pNP or MU standards in an 
identical buffer system for concentration 
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calibration. MU β-man hydrolysis was monitored 
continuously (λex = 365 nm and λem = 450 nm) 
while pNP β-man hydrolysis was measured after 
stopping the assay with a 1:1 ratio of 1M Na2CO3 
(pH 11.2).  
The specificity constant for the hydrolysis 
of mannobiose, mannotriose and mannotetraose 
was determined using an assay for reducing 
sugars employing bicinchonic acid (BCA). 
Reactions containing between 0.1 and 4 mM 
mannobiose were incubated at 25 ºC and aliquots 
were removed over a period of 30 min. These 
aliquots were added to an equal volume of freshly 
prepared BCA reagent containing: 400 mM 
sodium carbonate pH 11.2, 2.5 mM Bicinchonic 
acid, 1.25 mM CuSO4 and 2.5 mM L-serine. This 
mixture was heated to 80 ºC for 10 min, and then 
cooled. The absorbance at 563 nm was measured 
with a CLARIOstar Plus plate reader (BMG 
Labtech) and compared to a standard curve of 
mannose to calculate the concentration of 
reducing sugars. Data was fit to linear equation to 
give the specificity constant.  
To determine inhibition constant (Ki) 
values Michaelis-Menten parameters were 
determined for Bs164 hydrolysis of pNP β-man in 
reactions containing either mannoimidazole or 
noeuromycin. Assays were started with the 
addition of enzyme to the assay mix. Parameters 
were determined for at least 3 different inhibitor 
concentrations. Inhibition constants were 
calculated according to a competitive inhibition 
model for both inhibitors. All kinetic parameters 
were fit with the software program Origin 2019.  
 
SEC-MALS 
Experiments were conducted on a system 
comprising a Wyatt HELEOS-II multi-angle light 
scattering detector and a Wyatt rEX refractive 
index detector linked to a Shimadzu HPLC 
system (SPD-20A UV detector, LC20-AD 
isocratic pump system, DGU-20A3 degasser and 
SIL-20A autosampler). Work was conducted at 
room temperature (20 ±2 °C). Sample injection 
volume was 100 µL at a protein concentration of 
5 mg/ml. The samples were separated on a 
Superdex S200 10/300 (GE Healthcare) using 80 
mM MES pH 5.5, 200 mM NaCl as buffer. 
Shimadzu LC Solutions software was used to 
control the HPLC and Astra V software for the 
HELEOS-II and rEX detectors. Data were 
analysed using the Astra V software. MWs were 
estimated using the Zimm fit method (33) with 
degree 1. A value of 0.19 was used for protein 
refractive index increment (dn/dc). 
 
NMR  
Prior to NMR experiments buffer (80 mM 
MES pH 5.5 and 160 mM NaCl), pNP β-
mannoside and Bs164 were lyophilized. Buffer 
and enzyme were resuspended in D2O, while pNP 
β-mannoside was resuspended in 10 % d6-DMSO 
in D2O. The final reaction mixture contained 4.5 
mM pNP β-man, 9 mM MES (pH 5.5), 145 mM 
NaCl, and 0.9 % (v/v) d6-DMSO. NMR spectra 
were collected before the addition of enzyme and 
every 5 min after the addition of Bs164to a final 
concentration of 120 µg/mL. NMR data was 
collected on a Bruker 700 MHz Avance Neo 
spectrometer equipped with a 5 mm triple 
resonance cryoprobe. 1-D proton spectra were 
recorded with a 30 degree excitation pulse, an 
interscan delay of 10 s and a total acquisition time 
of 3 min. Sample temperature was maintained at 
298 K, and referencing was relative to DSS. 
 
Crystallization and structure determination  
His6-Bs164 at 30 mg/mL was tested against 
a range of commercial crystallization screens. 
Large split crystals were found in 100 mM 
ammonium tartrate dibasic pH 7.0, 12% w/v PEG 
3,350, a condition that was used for further 
optimization. Crystals formed in 0.1 M 
ammonium tartrate dibasic at a pH range from 5.5 
to pH 7.0. The optimized crystals were grown in 
maxi 48-well plates using the sitting-drop vapor-
diffusion method at 20 °C with 100 mM 
Ammonium tartrate dibasic pH 7.0, 13% w/v 
PEG 3,350 with a protein: well solution ration of 
500:500 nL. Crystals were soaked in well solution 
containing 25% (v/v) ethylene glycol before flash 
cooling in liquid nitrogen. Inhibitor complexes 
were obtained by soaking crystals in well solution 
containing 10 mM of the inhibitor for 3-4 h before 
flash cooling in liquid nitrogen. For the structures 
with DNP 2FM solid substrate was added to the 
drop containing crystals and which were then 
soaked overnight. The overnight soaking with 
crystals of DNP 2FM gave inhibitor complexes, 
but did appear to reduce diffraction quality. 
Refinement statistics are given in Table 2. 
Bs164 seleno-methionine derivative, 
mannoimidazole, noeuromycin, DNP 2FM 
diffraction data were collected at Diamond 
beamlines, and data were processed with the 
CCP4i2 suite (34). The unliganded structure of 
Bs164 was solved by MAD phasing of a seleno-
methionine derivative using 6 datasets: two at the 
peak wavelength (0.9794Å) using 0.1° oscillation 
and a χ angle of 25° or 0°, for 360°; two at a 
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remote wavelength (0.9777 Å) using 0.1° 
oscillation and a χ angle of 25° or 0°, for 360° and 
two at the inflection (0.9797 Å) using 0.1° 
oscillation and a χ angle of 25° or 0°, for 360°. 
Crank2 (35) was used for phasing and initial 
model building. Cycles of maximum-likelihood 
refinement using REFMAC5 (36) were 
interspersed with manual corrections of the 
models using COOT (37). Complexed structures 
of Bs164 were solved by molecular replacement 
using the unliganded coordinates as the search 
model in Phaser (38). Structural figures were 
drawn with PyMol (DeLano Scientific LLC, 
http://pymol.sourceforge.net/). 
 
Sequence Alignment  
All Seventeen GH164 sequences currently 
available in the CAZy database (5) (Accessed 01-
12-2019) were aligned using the COBALT 
multiple sequence alignment tool (39) and amino 
acid conservation was determined using the 
ConSurf server (40) and visualized in PyMol. 
 
Data availability 
The atomic coordinates and structure factors have 
been deposited in the Protein Data Bank. PDB ID 
codes: 6T5O, 6T75, 6T6G, 6T7G. 
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Table 1. Kinetic parameters of mannoside hydrolysis for Bs164 and mutants. 
* Estimated from limit of detection 
  
Enzyme Substrate kcat (s-1) KM (mM) kcat / KM(s-1• mM-1) 
Bs164 pNP β-man 40 ± 3 3.6 ± 0.8 11 ± 3 
Bs164 MU β-man 1.8 ± 0.05 1.05 ± 0.08 1.7 ± 0.1 
Bs164 Mannobiose - - 2.2 ±0.4 
Bs164 Mannotriose - - 5.6 ± 0.7 
Bs164 Mannotetraose - - 4.5 ± 0.7 
Bs164 _E297Q  pNP β-man 0.124 ± 0.003 0.87 ± 0.05 0.14 ± 0.01 
Bs164 _E160Q  pNP β-man - - < 10-6 * 
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Table 2. Data collection and refinement statistics 
  SeMet-Bs164 “Apo”-Bs164 
(6T5O) 
2-F-Mannose 
(6T75) 
Mannoimidazole 
(6T7G) 
Noeruomycin 
(6T6G) 
Data collection 
       
Space group P1 P1 P1 P1 P1 
Cell 
dimensions  
       
a, b, c (Å) 69.5, 104.5, 170.4 69.2, 103.9, 
169.2 
70.2, 104.9, 171.6 69.7, 104.7, 
170.6 
69.8, 105.1, 
170.5 
 α, β, γ (°) 92.3, 97.4, 106.2,  92.5 97.3, 
106.4 
 92.0, 97.7, 107.2  92.3, 97.3, 106.3  92.6, 97.2, 
105.1  
Peak Inflection Remote 
    
Wavelength 
(Å) 
0.9794 0.9797 0.9777 0.9795 0.9763 0.97623 0.9159 
Resolution (Å) 67.13-2.30 
(2.34-2.30) 
67.13-2.30 
(2.34-2.30) 
67.13-2.30 
(2.34-2.30) 
66.76-
1.91(1.94-
1.91) 
99.90-2.54 (2.59-
2.55) 
168.66-1.79 
(1.83-1.80) 
101.13-2.06 
(2.10-2.06) 
Rmerge 0.070 (0.297) 0.074 (0.338) 0.086 (0.477) 0.062 (0.546) 0.113 (1.073) 0.044 (0.548) 0.115 (1.039) 
I / σI 15.3 (4.9) 15.3 (4.7) 14.5 (4.0) 9.4 (1.6) 6.1 (1.0) 6.5 (1.1) 5.2 (1.0) 
Completeness 
(%) 
99.9 (97.9) 99.9 (97.9) 99.9 (97.9) 95.6 (93.1) 98.7 (98.0) 100.0 (100.0) 98.3 (97.4) 
Redundancy 7.0 (7.0) 7.0 (7.0) 7.0 (7.0) 3.2 (3.2) 3.6 (3.7) 2.0 (2.0) 3.5 (3.3) 
CC1/2 0.99 (0.96) 0.99 (0.95) 0.99 (0.98) 0.99 ( 0.73) 0.99 (0.46) 0.99 (0.66) 0.98 (0.60) 
        
Refinement               
Resolution (Å) 
   
1.91 2.55 1.80 2.06 
No. reflections 
   
332,570 148,575 454,150 280,985 
Rwork / Rfree 
   
0.19/0.22 0.21/0.245 0.21/0.23 0.21/0.24 
No. atoms 
       
Protein 
   
31506 31388 31597 31482 
Ligand/ion 
   
175/6* 66/6 148/6 90/6 
Water 
   
1902 159 1666 1029 
B-factors (Å ) 
       
Protein 
   
33 54 42 49 
Ligand/ion 
   
42/27 48/46 35/49 33/35 
Water 
   
34 40 43 37 
R.m.s. 
deviations 
       
Bond lengths 
(Å) 
   
0.008 0.009 0.008 0.01 
Bond angles (°) 
   
1.4 1.5 1.4 1.6 
       
 
*ligands in the uncomplexed structure are derived from ethylene glycol, tartrate / chloride 
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Figure 1. Genomic context of GH164 enzymes and mannan structure. (A)Genomic context of the 
GH164 genes present in the genomes of B. salyersiae, Alistipes sp. and C. sputigena. Locus tags are 
given above the arrows and predicted annotation is given below. Genes predicted to be GHs are 
highlighted in yellow, while the SusC-like and SusD-like proteins are shown in blue and burgundy 
respectively. Genes are not shown to scale. Hybrid two-component systems are abbreviated ‘HCTS’ 
while hypothetical proteins are annotated ‘Hyp’. None of the GH5 or GH16 genes are currently 
annotated as belonging to specific subfamilies.(B) Mannans and glucomannans contain β-1,4-linked D-
mannose residues in their structural backbone with glucomannans also containing backbone β-1,4-
linked D-glucose residues. This backbone can be decorated with acetyl groups at the 2- and 3-positions 
or with α-linked galactosyl groups at the 6-position, forming galactoglucomannans (41).  
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Figure 2. pH profile of Bs164 activity. Specificity constants for the hydrolysis of MU β-man were 
determined between pH 5.0 and 8.5 using substrate depletion kinetics. MES buffer was used between 
5.0 and 6.5 and HEPES buffer was used from pH 6.5-8.5. 
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Figure 3. Bs164 acts with retention of stereochemistry. pNP β-man was incubated with Bs164 and 
the stereochemistry of the reaction was monitored by 1H NMR spectroscopy. Before enzyme addition 
there are no anomeric protons corresponding to free mannose. At t = 3 min, a single new peak 
corresponding to the H1β of mannose is observed at δ 4.88 ppm. Mutorotation of the anomer results in 
a decrease in the H1β signal and an increase of the H1α signal at δ 5.16 ppm over time.  
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Figure 4. Structure of Bs164. The trimeric structure of Bs164 is shown in panel A. All three protomers 
are shown with a surface and each chain is displayed as a cartoon diagram coloured by domain. B shows 
the structure of one protomer. Domain A, which has a (β/α)8 fold, is shown in green with subdomain H 
is shown in magenta, domain B, containing a mixed β-sheet, is shown in red and the β-sandwich of 
domain C is shown in blue. Overlay of domain A of Bs164 and the catalytic domain of β-galactosidase 
from Rahnella sp. R3 (5E9A) is shown in panel C. Bs164 is in green while 5E9A is coloured blue. Both 
the catalytic nucleophile and acid/base residue of both structures are shown as sticks. The chlorine 
binding site of Bs164 is shown in D, with dashed lines showing polar interactions closer than 3.4 Å 
apart. Electron density for the chloride is a σA-weighted 2Fo-Fc density contoured at 3 σ and rendered 
with the program PyMol. The nucleophile residue Glu297 is also shown as it interacts with Arg73.  
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Figure 5. Conservation of GH164 surface. Surface representation of Bs164 colored by sequence 
conservation within the GH164 family. The figure was prepared using the CONSURF server (40) and 
generated in PyMol. The top representation is in the same orientation as Figure 3B. 
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Figure 6. Complexes of Bs164 with inhibitors. (A) Complex with noeuromycin (B) complex with 
mannoimidazole and (C) a complex with covalently bound 2-deoxy-2-fluoro-mannose. The top panel 
shows the inhibitor within the active site with polar interactions within 3.2 Å shown as black dashed 
lines. The middle panel shows the inhibitor with the surrounding electron density and the bottom panel 
shows a cartoon schematic of active site interactions. All electron density meshes are σA-weighted 2Fo-
Fc densities contoured at 1.5 σ and rendered with the program PyMol. Trp336, which sits below the 
inhibitors, has been omitted for clarity.  
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